Elif Sertesen Çamöz

Prognostic impact of the Gustave Roussy Immune score in metastatic renal cell carcinoma treated with first-line immunotherapy-based combinations: results from the Turkish Oncology Group Kidney Cancer Consortium (TKCC)

Abdullah Akkuş, Hatice Bölek, Esma Kaplan Tüzün, Elif Sertesen Çamöz et autres

tr, kh, ag (code pays fourni par la source)

Proteogenomic and single-cell dissection of immune heterogeneity in NSMP endometrial cancer reveals dual IDO1 programs

Osman Bilge Kaya, Berkan Karabuğa, Ergin Aydemir, Elif Sertesen Çamöz et autres

tr (code pays fourni par la source)

Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO)

Erman Akkus, M. Levent Kayaalp, Müzeyyen Aslı Ergözoğlu, Ilgın Koç Kuş et autres

tr (code pays fourni par la source)

Impact of first-line tyrosine kinase inhibitor selection on survival outcomes with second-line nivolumab in metastatic renal cell carcinoma

Omer F. Kuzu, Hatice Bölek, Elif Sertesen Çamöz, Hilal Karakaş et autres

tr, ag, in, kh, us (code pays fourni par la source)

Tumor-Infiltrating Lymphocytes—An Area of Standardization

Elif Sertesen Çamöz, İlknur Deliktaş Onur, Fatih Yıldız

tr (code pays fourni par la source)

Uric acid level in metastatic renal cell carcinoma treated with nivolumab: a Turkish Oncology Group Kidney Cancer Consortium (TKCC) study

Serhat Sekmek, Hatice Bölek, Omer F. Kuzu, Elif Sertesen Çamöz et autres

tr, in, kh, us (code pays fourni par la source)

Sunitinib in metastatic renal cell carcinoma: clinical outcomes across risk groups in a Turkish Oncology Group Kidney Cancer Consortium

Hatice Bölek, Omer F. Kuzu, Elif Sertesen Çamöz, Serhat Sekmek et autres

tr, in, ag, us (code pays fourni par la source)

Evaluating the prognostic role of glucose-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors in first line: a study by the Turkish Oncology Group Kidney Cancer Consortium (TKCC)

Hatice Bölek, Omer F. Kuzu, Elif Sertesen Çamöz, Serhat Sekmek et autres

tr, in, ag, kh, gb, us (code pays fourni par la source)

Is the Prognostic Nutritional Index a Novel Prognostic Factor in Patients With Unresectable/Metastatic Gallbladder and Cholangiocarcinoma Receiving Chemotherapy?

İlknur Deliktaş Onur, Hatice Gülgün Fırat, Elif Sertesen Çamöz, Fatih Yıldız

kh, tr (code pays fourni par la source)

SAT-518 Evaluation of the prognostic importance of Gustave Roussy immune score in hepatocellular carcinoma patients

Hatice Gülgün Fırat, İlknur Deliktaş Onur, Elif Sertesen Çamöz, Fatih Yıldız